Research
Independent analysis of SEC filings, private funds, RIAs, websites and regulatory records.
Is Savyon Ventures Fund II Legit? $10M Seed Fund, AI & Commerce Portfolio and Eran Savir Review 2026
Savyon Ventures Fund II, LP is a new seed-stage venture capital vehicle launched in 2026 by Israel-based Savyon Ventures and founder Eran Savir. Its September 17, 2026 Form D discloses a $10 million Rule 506(b) offering and identifies the issuer as a pooled investment fund. The public filing is relatively sparse, but the sponsor's operating footprint is much richer. Savyon Ventures presents itself as a specialized, operator-led seed investor focused on AI, digital and commerce companies, with a preference for startups that have already demonstrated initial revenue rather than pre-product concepts. The firm says it typically invests around $250,000 per company, can lead, co-lead or follow seed rounds, offers LP co-investment opportunities and prefers Israel and U.S./Delaware companies while remaining globally flexible. Its public portfolio includes Quack, Underoutfit, Clears.ai, Shopeaks, Wiserpay, iBrick and renn, among others, while third-party startup databases also connect Eran Savir to earlier investments such as SensePass, Matics, Pairzon, Revuze and Fixel.ai. Quack provides the clearest realized evidence because Savyon's own site now labels the AI customer-support company as acquired by AUI. The manager also publicly claims that Savir previously managed two seed-stage VC portfolios that produced a 3.5x TVPI and 79% IRR in approximately four years with five exits. Those numbers are potentially impressive but should be treated as sponsor-reported historical performance rather than audited Fund II results. The strongest conclusion today is that Savyon Fund II is a real successor fund backed by an identifiable Israeli venture platform, a visible founder, a documented portfolio and at least one recent exit; the main diligence questions are how much of the $10 million target has actually closed, whether prior performance claims are independently verified, how Fund I performed net of fees, and whether such a small Fund II can maintain adequate diversification and follow-on reserves across a highly competitive AI seed market.
Savyon Ventures Fund II, LP · CIK 0002155668Read article →Is Allied Industrial Partners Fund II Legit? Fund II-A / II-B Structure, $300M Fund I, $1B+ AUM and Industrial Private Equity Review 2026
Allied Industrial Partners II-A LP and Allied Industrial Partners II-B LP are newly formed Delaware private investment vehicles launched in September 2026 by Houston-based Allied Industrial Partners, an operationally focused lower-middle-market private equity firm founded in 2019 by Bradford Rossi and Philip Wright. Both Fund II vehicles filed Form D notices on September 17, 2026 under Rule 506(b), use the same 4909 Bissonnet Street, Houston address and identify Allied Industrial Partners II GP, LP as general partner and Allied Industrial Partners LLC as promoter. The filings currently do not disclose a target offering size, amount sold or investor count, which means Fund II appears to be at an early fundraising stage and should not yet be described as having raised a specific amount. What makes the new fund credible is the depth of the sponsor's recent operating history. Allied closed its first institutional fund, Allied Industrial Partners I-A and I-B, in April 2025 at a $300 million hard cap after exceeding its original $250 million target, and stated that the close pushed firmwide AUM above $1 billion. More than 10% of Fund I was committed by Allied's senior team, while investors included pensions, insurance companies, financial institutions, foundations, funds-of-funds and family offices. Allied also disclosed that it had invested more than $200 million of equity across five investments before Fund I and expected Fund I to be more than 70% deployed or allocated by year-end 2025. Since formation, the firm has built an unusually visible portfolio across temporary power, waste and recycling, industrial services, electrical distribution and critical infrastructure and has executed dozens of bolt-on acquisitions. By 2026 the platform had current investments including CES Power, Mat Tech Industrial Services, Celebrity Coaches, JCL Energy, Pride Dynamo and Trinity Industrial, while Dovetail Infrastructure Services, Waste Eliminator and Liberty Waste Solutions had moved into the realized portfolio. Fund II therefore has a strong sponsor-continuity and operating-verification trail even though the new vehicle's own economics remain largely undisclosed. The principal diligence questions are the final Fund II target size, the exact relationship between II-A and II-B, management fees and carried interest, GP commitment, sector concentration, acquisition leverage and whether Allied can reproduce Fund I's early operating results as it scales into a larger second-generation program.
Allied Industrial Partners Fund II · CIK 0002132962Read article →Is Keyrock Strategic Fund Legit? $38.2M Raised Across Strategic and Offshore Vehicles, Hong Kong SFC Manager and Fund History Review 2026
Keyrock Strategic Fund is a Cayman Islands exempted company formed in 2025 and managed by Hong Kong-based Keyrock Capital Management Limited. Its September 17, 2026 Form D reports an indefinite Rule 506(b) offering, $3 million sold to two investors, a $100,000 minimum investment and Section 3(c)(7) status. On the same day, Keyrock Strategic Offshore Fund filed a near-parallel Form D reporting approximately $35.245 million sold to five investors, also with a $100,000 minimum, Rule 506(b), Section 3(c)(7), the same Cayman registered office, the same manager and the same first-sale date of August 18, 2026. The two vehicles therefore appear to belong to one broader Strategic Fund structure, although the exact relationship between the main and Offshore vehicles should be confirmed from offering documents before simply adding their assets together. The combined Form D securities sold across the two vehicles are approximately $38.245 million, but that figure should not automatically be described as unique NAV or AUM because parallel and offshore fund structures can hold overlapping or feeder-level economic exposure. The manager itself has a much longer track record than the 2025 fund formation date suggests. Keyrock Capital Management Limited is a Hong Kong investment manager founded in 2018 and licensed by the Hong Kong Securities and Futures Commission for Type 9 asset management. Its own website says it focuses on Asia-Pacific companies, particularly technology, consumer and services businesses, with a multi-year investment horizon and capital from both the partners and institutional investors. Jonathan Hung-yee Shih is identified in the new Form D filings as director and executive officer, and public SFC-derived records show him as a current Responsible Officer for Type 9 asset management. SEC filings also show that the same manager and Jonathan Shih have been associated with Keyrock Capital Onshore Fund and Keyrock Capital Offshore Fund since 2018-2019 and with Keyrock Opportunities SPC by 2022, creating a clear multi-fund regulatory history. The strongest current conclusion is therefore that Keyrock Strategic Fund is a verifiable continuation of an established Hong Kong investment platform, but investors still need the 2026 portfolio, gross and net exposure, concentration, liquidity, leverage and fee terms before judging the actual risk of the new Strategic strategy.
Keyrock Strategic Offshore Fund · CIK 0002155053Read article →Is Thrive Capital Partners VI-K Legit? $7.42M Raised, 11 Investors and Thrive Capital Structure Review 2026
Thrive Capital Partners VI-K, LLC is a Delaware pooled investment vehicle formed in 2026 and managed through Thrive Capital Management, LLC, the New York venture capital firm founded by Joshua Kushner. Its September 17, 2026 Form D reports a $7,419,063 Rule 506(b) offering that was fully sold to 11 investors and relies on Section 3(c)(7). The vehicle uses Thrive Capital's 295 Lafayette Street, New York headquarters and sits inside the same legal and management ecosystem as earlier Thrive Capital Partners VI entities and the much larger Thrive Capital Partners X family launched in 2025–2026. The most important point is that VI-K should not be interpreted as Thrive's principal current flagship fund merely because of its name. Thrive's original sixth-generation flagship structure dates back to 2018, when Thrive Capital Partners VI and Thrive Capital Partners VI Growth together raised an aggregate $1 billion, split between a $400 million venture fund and a $600 million growth vehicle. VI-K, by contrast, is a much smaller 2026 LLC with only $7.419 million sold. That large difference strongly suggests VI-K is a side vehicle, parallel vehicle, internal allocation structure, employee or strategic investor vehicle, or other specialized continuation of the VI legal family rather than a new $7.4 million flagship strategy. Public Form D records do not define its exact purpose, so that interpretation should remain qualified. The broader manager, however, is highly verifiable: Thrive Capital Management has been active for years across venture and growth investing, has launched multiple large institutional fund families and remains closely associated with major private technology companies including OpenAI, Databricks, Stripe and other late-stage technology leaders. The main diligence issue is therefore not whether the Thrive platform is real, but what VI-K specifically owns, why it was formed eight years after the original Fund VI launch and whether its economics, portfolio and investor rights differ from the main Thrive funds.
Thrive Capital Partners VI-K, LLC · CIK 0002110466Read article →Is Inland MN Medical Apartment Development Legit? $57.8M Offering, Inland Private Capital and Healthcare Real Estate Review 2026
Inland MN Medical Apartment Development, L.L.C. is a Delaware real estate investment vehicle formed in 2026 and sponsored by Inland Private Capital Corporation, one of the largest private real estate program sponsors in the Inland Investments platform. Its September 17, 2026 Form D launches a $57,797,210 Rule 506(b) equity offering with a $50,000 minimum investment and reports that the first sale has not yet occurred, meaning no outside capital had been sold as of the filing date. The issuer is classified under Other Real Estate rather than a pooled investment fund, and Inland Private Capital Corporation is directly named as sponsor, while Inland MN Med Apt Development Manager, L.L.C. is identified as the manager. Inland Securities Corporation, CRD 15807, is the placement agent and is eligible to solicit investors across all U.S. states. The filing indicates approximately $2.89 million of potential sales compensation if the offering is fully sold, equal to roughly 5% of the total offering amount. The project therefore has a clear and verifiable sponsor, manager and distribution chain. Inland's broader platform is also substantial: its December 2025 private-investments portfolio overview reported approximately $13.4 billion of AUM, 334 sponsored programs, 988 acquired properties, more than $19 billion of acquisitions and more than $5.4 billion of completed full-cycle asset dispositions. Inland also reported that healthcare and senior-living programs sponsored through Inland Private Capital had acquired more than $1.6 billion of assets by year-end 2025. The principal weakness is project-level transparency. The public Form D does not identify the exact Minnesota property, development address, apartment count, medical component, tenant or operator, construction lender, land cost, development budget or projected stabilization date. For that reason, the strongest current conclusion is that Inland MN Medical Apartment Development is a verified Inland-sponsored offering backed by a large and experienced real estate platform, but investors still need the offering memorandum and project documents to understand exactly what the $57.8 million is intended to build.
Inland MN Medical Apartment Development, L.L.C. · CIK 0002153162Read article →Is Future Labs Capital Fund II Legit? $65M AI & Quantum Venture Fund, MIT CSAIL Partnership and Portfolio Review 2026
Future Labs Capital Fund II, L.P. is a Delaware venture capital fund formed in 2024 and operated from 280 Missouri Avenue in Jeffersonville, Indiana. Its September 17, 2026 Form D reports a $65 million Rule 506(b) offering, $6.5 million sold, $58.5 million remaining and 25 investors, with the first sale dating to March 4, 2025. The filing classifies the vehicle specifically as a Venture Capital Fund and relies on Section 3(c)(1). Future Labs Capital II, LLC is the general partner; Future Labs, LLC is a managing member of that GP; Hugh "Mack" Shwab is identified as manager and member of Future Labs, LLC; and Michael W. Kosloske appears through Gucci Holdings, LLC, another managing member of the GP. One of the most useful disclosures is Item 16 of the Form D: the fund reports $104,300 of offering proceeds paid as management fees to the GP for the period from January 10, 2025, when operations commenced, through December 31, 2025. The manager's public strategy is unusually specific. Future Labs Capital focuses on early-stage artificial intelligence and quantum-computing companies and maintains a formal relationship with MIT's Computer Science and Artificial Intelligence Laboratory, or CSAIL. MIT itself published a detailed April 2026 case study describing Future Labs Capital as a CSAIL Alliances affiliate, confirming that the firm has used that relationship to source early-stage companies from MIT research and that it became the first investor in Atlantic Quantum before the company was later acquired by Google Quantum AI. This combination of SEC filings, MIT institutional evidence, an identifiable first fund and real portfolio transactions makes the manager substantially more verifiable than a newly formed venture fund with only a Form D. The main diligence issues are Fund II's still-early fundraising stage, the degree to which Fund I's reported results can be independently verified, concentrated exposure to technically difficult AI and quantum startups, valuation risk and whether a relatively small investment organization can successfully scale from its first fund into a $65 million successor vehicle.
Future Labs Capital Fund II, L.P. · CIK 0002154534Read article →Is Turning Rock Fund IV Legit? $235.5M Raised, $25M Co-Investment Vehicle and Turning Rock Partners Review 2026
Turning Rock Fund IV LP is a newly launched Delaware private equity vehicle managed by Turning Rock Partners, L.P., an established New York private investment manager focused on bespoke debt, equity and hybrid capital for lower-middle-market businesses. Its September 17, 2026 Form D reports an indefinite Rule 506(b) / Section 3(c)(7) offering with $235.5 million sold to only four investors following a first sale on September 3, 2026. A second vehicle, TRP Fund IV Co LP, filed on the same date with the same manager, GP structure, first-sale date and Section 3(c)(7) exemption and reported another $25 million sold to one investor. These vehicles should be analyzed as part of the same Fund IV ecosystem rather than automatically added together as $260.5 million of distinct assets because the "Co" vehicle may represent a parallel, co-investment or transaction-specific structure. The regulatory identity is unusually strong: Turning Rock Partners, L.P. is an SEC-registered investment adviser, not merely an exempt reporting adviser, under CRD 287608 and SEC File No. 801-111986, with its principal office at 350 Madison Avenue in New York. 2026 ADV-derived data reports approximately $1.4 billion of regulatory assets under management, 21 employees and 11 advisory accounts. SEC Fund IV filings identify Maggie Arvedlund as CEO, Saba Ahmad as President and David Markus as Partner, while Turning Rock Partners GP IV LLC is the general partner. The public operating record also extends well beyond regulatory filings: Turning Rock has announced debt, equity and hybrid investments across aviation, automotive services, transportation training, wealth management, food manufacturing, communications infrastructure and healthcare services, together with multiple realized exits. The central diligence question is therefore not whether Turning Rock or Fund IV exists, but how Fund IV allocates capital across direct lending, structured equity, asset-backed finance and control or minority investments, how concentrated the first four LPs are, and whether the new fund can reproduce returns achieved through earlier Turning Rock transactions.
Turning Rock Fund IV LP · CIK 0002153352Read article →Is KSL Capital Partners Credit Opportunities Fund V Legit? $1.035B Raised, 21 Investors and Travel & Leisure Private Credit Review 2026
KSL Capital Partners Credit Opportunities Fund V, L.P. is the fifth-generation private credit vehicle of KSL Capital Partners, a Denver-based alternative investment manager focused exclusively on travel and leisure. The fund was formed in Delaware in 2026 and filed its initial Form D in April before any sales had occurred. After another zero-sales amendment in June, the September 17, 2026 amendment reported approximately $1.0353 billion sold to 21 investors, making Fund V one of the larger new private credit vehicles appearing in SEC Form D filings this year. The fund relies on Rule 506(b) and Section 3(c)(7), is classified as a private equity / pooled investment fund for Form D purposes and uses 100 St. Paul Street, Suite 800, Denver, Colorado 80206 as its principal address. KSL Capital Partners CO Fund V GP, L.P. and KSL Ultimate GP, LLC appear in the fund structure, while executives named across the filings include Craig Henrich, Eric Resnick, John Ege, Peter McDermott, Kevin Neher, Marty Newburger, Daniel Rohan, Hal Shaw and Steven Siegel. The most important structural detail is that the main fund is accompanied by KSL Capital Partners Credit Opportunities Fund V FF, L.P. and KSL Capital Partners Credit Opportunities Fund V (Offshore) Feeder, L.P. The same September 17 filing cycle reported approximately $4.11 million sold in the FF vehicle and $10.15 million in the Offshore Feeder. These figures should not simply be added to the $1.035 billion main-fund number because feeder vehicles generally route capital into the same investment program and can create double-counting if treated as separate economic assets. The public evidence strongly supports fund identity, manager continuity and institutional fundraising scale. The principal diligence questions are therefore portfolio composition, loan seniority, hotel and resort collateral quality, leverage, covenant protection, borrower concentration, current yields, defaults and how Fund V's economics compare with the successful predecessor Credit Fund IV.
KSL Capital Partners Credit Opportunities Fund V, L.P. · CIK 0002129387Read article →Is Vector Line Capital Legit? Fund I at $300M, Fund II at $1.6B and Geoffrey Baldwin Private Equity Review 2026
Vector Line Capital is one of the most unusual new private equity platforms in this research series because its 2026 regulatory filings show very large offerings completed in a remarkably short period with only one investor reported in each fund. Vector Line Capital Fund I, LP was formed in Delaware in 2026 and began selling interests on April 7, 2026. Its original April filing reported a $300 million offering with $120 million sold to one investor; by September 17, 2026 the amendment reported the entire $300 million sold with zero remaining. Vector Line Capital Fund II, LP was also formed in 2026, began selling on May 1, and initially disclosed a $1.0 billion offering with approximately $550 million sold. By September 17, 2026 Fund II's offering had expanded to $1.6 billion and the full $1.6 billion was reported sold, again to only one investor. Both funds are classified as private equity funds, rely on Rule 506(b) and Section 3(c)(7), report no sales commissions or finder's fees, use the same Jackson, Wyoming address and phone number, and identify Geoffrey Baldwin as Managing Member of the relevant general partner. Vector Line Capital, LLC separately entered the SEC investment-adviser reporting system in April 2026 as an Exempt Reporting Adviser under CRD 342161 and SEC File No. 802-136269. This combination strongly supports the existence of a real private investment platform, but the scale and concentration make the central diligence question very different from a conventional private equity fund: who is the single LP in each vehicle, what assets or transactions were funded, and whether the reported $1.9 billion aggregate securities sales represent two economically distinct portfolios or related institutional mandates.
Vector Line Capital · CIK 0002120473Read article →Is Arcventis Health Fund Legit? $32.8M Raised, MPowered Capital Backing and Healthcare Growth Equity Review 2026
Arcventis Health Fund, L.P. is a newly launched Delaware healthcare investment fund with a far deeper team and institutional-support story than its 2025 formation date might initially suggest. The September 17, 2026 Form D/A reports an indefinite Rule 506(c) offering with $32.8 million sold to 13 investors, Section 3(c)(7) status and pooled investment fund interests. The fund was previously named HealthBridge Innovation Fund, L.P., while the management firm itself operated publicly as HealthBridge Innovation Partners before rebranding to Arcventis Health Partners in 2026. SEC records identify Richard Pines and Fazeela Abdul Rashid as executive officers and managing members of the general partner. The team's experience is unusually substantial for a first-time branded fund: Abdul Rashid previously spent roughly 11 years at Temasek, where she helped build U.S. healthcare investing, and later worked at Revolution Growth; Pines previously co-founded Athyrium and helped raise approximately $3.7 billion across three healthcare-focused funds before launching his own advisory platform. Arcventis also has an institutional launch partner: MPowered Capital publicly states that it invested in the firm through its GP Structured Partnership strategy and provides operational and strategic support through its Multiplier Program. The strongest conclusion is therefore that Arcventis is a genuine emerging healthcare private-markets platform backed by experienced investors and a third-party GP capital provider. The main diligence issues are portfolio transparency, first-fund execution risk, valuation discipline, healthcare regulatory complexity and whether a relatively new organization can translate its founders' prior track records into a repeatable standalone fund performance record.
Arcventis Health Fund, L.P. · CIK 0002092433Read article →Is BLX Lot 27 Fund Legit? $99.2M Raised, $224.8M Offering and Extell Deer Valley East Village Review 2026
BLX Lot 27 Fund LLC is a Delaware real estate investment vehicle formed in 2025 and directly connected to Extell Development Company's large Deer Valley East Village project in Utah. Its September 17, 2026 Form D/A reports a $224.8 million Rule 506(b) equity offering, $99.2 million sold and $125.6 million remaining, following an original September 2025 filing that targeted $120 million before any sales had occurred. The first sale took place on October 17, 2025. SEC records identify BLX Lot 27 Fund Manager LLC as manager, BLX Lot 27 Member LLC as member, Extell Utah Regional Center LLC as sponsor, Gary Barnett as project company manager and BLX Lot 27 Holdings LLC as borrower. All use Extell's 805 Third Avenue, New York address, making the Extell connection direct rather than inferred. The strongest property-level evidence comes from Utah's Military Installation Development Authority, which identifies Lot 27 within the North Mayflower / Deer Valley East Village master development as part of the Skier Services Complex and names Extell Development as applicant. MIDA approvals describe Tower B as a 16-story condominium structure with 55 residential units and Tower C as a 14-story structure with 68 residential units, plus podium commercial space, hotel-unit designations, parking and common elements. The legal disclosure on the official Waldorf Astoria Deer Valley residences website separately names BLX Lot 27 B LLC and BLX Lot 27 C LLC among the project sponsors, directly tying the "BLX Lot 27" naming convention to the branded-residence development now being marketed at Deer Valley East Village. This provides an unusually strong fund-to-project verification trail. The main diligence issues are not whether the project exists, but how the $224.8 million offering is allocated across land, construction, branded residences, hotel components, debt and related entities; whether Lot 27 economics are distinct from adjacent Lot 5 Waldorf Astoria components; and how construction, sales, leverage and resort-market risks affect investor returns.
BLX Lot 27 Fund LLC · CIK 0002088638Read article →Is Rockefeller Private Equity Select Opportunities Fund I-B Legit? $252.9M Raised, Rockefeller & Co. and Institutional Private Equity Review 2026
Rockefeller Private Equity Select Opportunities Fund I-B LP is a Delaware private equity fund launched in 2025 and managed through Rockefeller & Co. LLC at 45 Rockefeller Plaza in New York. Its September 17, 2026 Form D/A reports an indefinite Rule 506(b) offering with approximately $252.9 million sold since the first sale on September 22, 2025. The fund is classified as a private equity fund and pooled investment vehicle, and the filing identifies RSOF I LLC as general partner and Rockefeller & Co. LLC as investment manager. Rockefeller Financial LLC appears in 2026 filing databases as an associated broker/dealer for the offering, while the Form D itself states that placement-agent fees are paid according to a fee schedule and that the general partner is entitled to carried interest and the investment manager to a management fee. The fund also has a near-identical parallel vehicle, Rockefeller Private Equity Select Opportunities Fund I-A LP, which filed on the same day, reports the same approximately $252.9 million sold, uses the same Rockefeller address and manager entities, and began selling on the same date. This strongly suggests that I-A and I-B are parallel access vehicles within one broader investment program rather than two unrelated funds. Even more important, Canadian regulatory documents show that IG Investment Management sought and obtained relief allowing Canadian mutual funds to invest in Rockefeller Private Equity Select Opportunities Fund I-B as an underlying non-redeemable private investment fund managed by Rockefeller Capital Management. That third-party institutional evidence materially strengthens the fund's credibility and clarifies its intended role: a long-duration private equity allocation rather than a liquid trading fund. The main due-diligence issues are therefore not identity verification but the exact underlying private investments, I-A versus I-B economics, capital-call structure, total fee layering, valuation policy, illiquidity, manager-selection risk and how institutional investors are treated relative to other limited partners.
Rockefeller Private Equity Select Opportunities Fund I-B LP · CIK 0002075573Read article →